Academic Bibliography

Show Sort by

Your filters: cql: parent exact "ANNALS OF ONCOLOGY"

Mark
Second hit landscape in BRCA1/2-associated breast cancer

Mattias Van Heetvelde (UGent) , Mieke Van Bockstal (UGent) , Trees Lepez (UGent) , Kathleen Lambein, Dieter Deforce (UGent) , Anne Vral (UGent) , Bruce Poppe (UGent) , Kim De Leeneer (UGent) , Jo Van Dorpe (UGent) and Kathleen Claes (UGent)

(2017) ANNALS OF ONCOLOGY. 28(suppl. 1).
Mark
The potential and perils of observational studies

M Buyse and Stijn Vansteelandt (UGent)

(2017) ANNALS OF ONCOLOGY. 28(1). p.182-182
Mark
- conference
- C3
mRNA capture sequencing enabled liquid biopsy screening

Jo Vandesompele (UGent)

(2017) ANNALS OF ONCOLOGY. 28(suppl. 5).
Mark
Stromal inflammation, necrosis and HER2 overexpression in ductal carcinoma in situ of the breast : another causality dilemma?

Mieke Van Bockstal (UGent) , L Libbrecht, G Floris, K Lambein and S Pinder

(2017) ANNALS OF ONCOLOGY. 28(9). p.2317-2317
Mark
Integrating communication as a core skill in the global curriculum for medical oncology

Melissa Horlait (UGent) , M Leys, J De Grève and Simon Van Belle (UGent)

(2017) ANNALS OF ONCOLOGY. 28(3). p.670-671
Mark
- conference
- C3
A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy

B Verma, A Awada, P Aftimos, P Lewalle, N Meuleman, J-P Machiels, G Catala, E Vandenneste, J Brayer, D Sallman, et al.

(2017) ANNALS OF ONCOLOGY. 28(suppl. 5).
Mark
- conference
- C3
Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

E Seront, S Schmitz, Sylvie Rottey (UGent) , S Henry, C Lonchay, G van Caloen, A Gilain and J-P Machiels

(2016) ANNALS OF ONCOLOGY. 27(suppl. 6).
Mark
- journalArticle
- A1
- open access
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

JS Whelan, SS Bielack, N Marina, S Smeland, G Jovic, JM Hook, M Krailo, J Anninga, T Butterfass-Bahloul, T Böhling, et al.

(2015) ANNALS OF ONCOLOGY. 26(2). p.407-414
Mark
Stromal protein expression in breast cancer is differentially regulated by TGF-β1

Mieke Van Bockstal (UGent) , Kathleen Lambein (UGent) , Mireille Van Gele (UGent) , Elly De Vlieghere (UGent) , Ridha Limame, Geert Braems (UGent) , Marc Bracke (UGent) , Hannelore Denys (UGent) , Louis Libbrecht (UGent) and Olivier De Wever (UGent)

(2015) ANNALS OF ONCOLOGY. 26(suppl. 3).
Mark
- conference
- C3
Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect

Katrien De Wolf, Piet Ost (UGent) , VIBEKE KRUSE (UGent) , Lieve Brochez (UGent) and INES CHEVOLET (UGent)

(2015) ANNALS OF ONCOLOGY. 26(suppl. 8). p.7-7

Academic Bibliography

Second hit landscape in BRCA1/2-associated breast cancer

The potential and perils of observational studies

mRNA capture sequencing enabled liquid biopsy screening

Stromal inflammation, necrosis and HER2 overexpression in ductal carcinoma in situ of the breast : another causality dilemma?

Integrating communication as a core skill in the global curriculum for medical oncology

A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy

Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

Stromal protein expression in breast cancer is differentially regulated by TGF-β1

Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect

Contents

Support

Contact